The Right Medicare Drug Plan Can Help Control Price Shocks
Drug plans offered by private insurers under Medicare change from year to year. It pays to check around for the best deal during open enrollment season.
Pharmaceuticals
Bill Would Add Nurses, Physician Assistants To Pharma Disclosure Database
Drugmakers disclose their payments to doctors, dentists, even chiropractors. But spending on nurse practitioners and physician assistants is excluded. Legislation in the Senate would change that.
Pruning Back Prescriptions For Better Health
There comes a time when a drug that once helped a patient may be unnecessary or even harmful. Figuring out when to cut back is difficult, but the potential benefits are substantial.
FDA Approves First Drug To Boost Women's Sexual Desire
The daily pill, called Addyi, modestly increased women's interest in sex in clinical tests. The approval was praised by some women's advocates as a milestone and condemned by others as irresponsible.
Price Rises For Ticket To A Quicker Drug Review By FDA
A voucher that can get a drug through the Food and Drug Administration faster was created to reward companies that develop medicines for neglected diseases. The market for vouchers is heating up.
High Cost Of Diabetes Drugs Often Goes Overlooked
Cost increases for both old and new diabetes drugs are forcing many patients to scramble to pay for them.
Doctors Press For Action To Lower 'Unsustainable' Prices For Cancer Drugs
More than a hundred influential doctors banded together to propose seven ways to bring down the high prices of cancer drugs. They say changes are needed to preserve access to care.
Should Doctors And Drugmakers Keep Their Distance?
One doctor rethinks his hardline stance against contact with industry. Beyond drugmakers' sales and marketing, perhaps there's room for productive and ethical collaboration to advance medicine.
Bill To Boost Medical Research Comes With A Catch
The House of Representatives has approved a bill that would increase National Institutes of Health funding and ease rules for the approval of new drugs. But the Senate may not go along.
Industry Payments To Doctors Are Ingrained, Federal Data Show
The latest data on payments from drug and device companies to doctors show that many doctors received payments on 100 or more days last year. Some received payments on more days than they didn't.